Cardiovascular diseases remain a leading cause of mortality globally, particularly among individuals with both obstructive sleep apnea (OSA) and metabolic syndrome (MetS).
The partnership will aim to educate Saudi healthcare professionals on atherosclerotic cardiovascular disease to reduce mortality and improve heart health.